receptors as therapeutic targets in stress-related disorders.
And for the markers of inflammation we measured tachykinins
, substance P and neurokinin A.
receptors as potential therapeutic targets in visceral diseases.
The broad-spectrum antiemetic activity of the novel non-peptide tachykinin
NK1 receptor antagonist GR203040.
Another of the leads is a tachykinin
splice variant that exhibits a specific activity in the peripheral nervous system.
OA-519 - Opiod Peptides - P-glycoprotein - Pancreatic Oncofetal Antigen (POA) - Placental Lactogen - PR92 - Proliferative Index, Ki-67 - Px - RB Inactivation/Deletion - Ret - SCCL 175 - Selectin - Sialic Acid - Sialyl SSEA-1/SLX - SN10 - Somatostatin - TA-90 - TABA - Tachykinin
- TAG 12 - TPS - Troponin - Tubulin - VCAM - VEGF
2005), and activation effect of tachykinin
degrading enzymes (Miyata et al.